Prediction of causal candidate genes in coronary artery disease loci

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 10, 2015, Pages 2207-2217

  Brnne, Ingrid ^a,b,c   Civelek, Mete ^d   Vilne, Baiba ^f   Di Narzo, Antonio ^g   Johnson, Andrew D ^h   Zhao, Yuqi ^e   Reiz, Benedikt ^a,b,c   Codoni, Veronica ^i,j,k   Webb, Thomas R ^l   Asl, Hassan Foroughi ^m   Hamby, Stephen E ^l   Zeng, Lingyao ^f   Trégouët, David Alexandre ^i,j,k   Hao, Ke ^g   Topol, Eric J ⁿ   Schadt, Eric E ^g   Yang, Xia ^e   Samani, Nilesh J ^l   Björkegren, Johan L M ^g,m   Erdmann, Jeanette ^a,b,c   Schunkert, Heribert ^f   Lusis, Aldons J ^d   more..

^a UNIVERSITY OF LÜBECK   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c University Heart Center   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h FRAMINGHAM HEART STUDY   (United States)

ⁱ INSERM   (France)

^j SORBONNE UNIVERSITÉ   (France)

^k ICAN Institute for Cardiometabolism and Nutrition   (France)

^l UNIVERSITY OF LEICESTER   (United Kingdom)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

more..

Author keywords

Coronary artery disease; Genome wide association study; microRNAs; Single nucleotide polymorphism; Systems biology

Indexed keywords

AMINO ACID; MICRORNA; RIBOSOME RNA; SMALL NUCLEAR RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNTRANSLATED RNA;

3' UNTRANSLATED REGION; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; NONHUMAN; OPEN READING FRAME; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS; RNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MALE; PATHOPHYSIOLOGY; PREDICTIVE VALUE;

CORONARY ARTERY DISEASE; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS, GENETIC;

EID: 84942242979     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306108     Document Type: Article

References (58)

1. Deloukas P, Kanoni S, Willenborg C, et al; CARDIoGRAMplusC4D Consortium; DIAGRAM Consortium; CARDIOGENICS Consortium; MuTHER Consortium; Wellcome Trust Case Control Consortium. Largescale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25-33. doi: 10. 1038/ng. 2480.
2. BjÖrkegren JL, Kovacic JC, Dudley JT, Schadt EE. Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. J Am Coll Cardiol. 2015;65:830-845. doi: 10. 1016/j. jacc. 2014. 12. 033.
3. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466:714-719. doi: 10. 1038/nature09266.
4. Jansen H, Samani NJ, Schunkert H. Mendelian randomization studies in coronary artery disease. Eur Heart J. 2014;35:1917-1924. doi: 10. 1093/ eurheartj/ehu208.
5. Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337:1190-1195. doi: 10. 1126/science. 1222794.
6. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. Traitassociated SNPs are more likely to be eQTLs: Annotation to enhance discovery from GWAS. PLoS Genet. 2010;6:e1000888. doi: 10. 1371/journal. pgen. 1000888.
7. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M. Linking disease associations with regulatory information in the human genome. Genome Res. 2012;22:1748-1759. doi: 10. 1101/gr. 136127. 111.
8. Flister MJ, Tsaih SW, O'Meara CC, Endres B, Hoffman MJ, Geurts AM, Dwinell MR, Lazar J, Jacob HJ, Moreno C. Identifying multiple causative genes at a single GWAS locus. Genome Res. 2013;23:1996-2002. doi: 10. 1101/gr. 160283. 113.
9. Consortium GT. Human genomics. The genotype-tissue expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science. 2015;348:648-660.
10. Ward LD, Kellis M. HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930-D934. doi: 10. 1093/nar/gkr917.
11. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24:2938-2939. doi: 10. 1093/bioinformatics/btn564.
12. Pruitt KD, Brown GR, Hiatt SM, et al. RefSeq: An update on mammalian reference sequences. Nucleic Acids Res. 2014;42(Database issue):D756-D763. doi: 10. 1093/nar/gkt1114.
13. Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 2012;22:1760-1774. doi: 10. 1101/gr. 135350. 111.
14. Flicek P, Amode MR, Barrell D, et al. ENSEMBL 2014. Nucleic Acids Res. 2014;42(Database issue):D749-D755. doi: 10. 1093/nar/gkt1196.
15. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164. doi: 10. 1093/nar/gkq603.
16. Liu X, Jian X, Boerwinkle E. dbNSFP v2. 0: A database of human nonsynonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013;34:E2393-E2402. doi: 10. 1002/humu. 22376.
17. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310-315. doi: 10. 1038/ng. 2892.
18. Eicher JD, Landowski C, Stackhouse B, Sloan A, Chen W, Jensen N, Lien JP, Leslie R, Johnson AD. GRASP v2. 0: An update on the Genome-Wide Repository of Associations between SNPs and phenotypes. Nucleic Acids Res. 2015;43(Database issue):D799-D804. doi: 10. 1093/nar/gku1202.
19. Foroughi Asl H, Talukdar HA, Kindt AS, et al; CARDIoGRAM Consortium. Expression quantitative trait loci acting across multiple tissues are enriched in inherited risk for coronary artery disease. Circ Cardiovasc Genet. 2015;8:305-315. doi: 10. 1161/CIRCGENETICS. 114. 000640.
20. Zhong H, Beaulaurier J, Lum PY, et al. Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet. 2010;6:e1000932. doi: 10. 1371/journal. pgen. 1000932.
21. Rotival M, Zeller T, Wild PS, et al; Cardiogenics Consortium. Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans. PLoS Genet. 2011;7:e1002367. doi: 10. 1371/journal. pgen. 1002367.
22. Erbilgin A, Civelek M, Romanoski CE, Pan C, Hagopian R, Berliner JA, Lusis AJ. Identification of CAD candidate genes in GWAS loci and their expression in vascular cells. J Lipid Res. 2013;54:1894-1905. doi: 10. 1194/jlr. M037085.
23. Wild PS, Zeller T, Schillert A, et al. A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet. 2011;4:403-412. doi: 10. 1161/ CIRCGENETICS. 110. 958728.
24. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, Dilthey A, Ellis P, Langford C, Vannberg FO, Knight JC. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet. 2012;44:502-510. doi: 10. 1038/ng. 2205.
25. Willer CJ, Schmidt EM, et al; Global Lipids Genetics C. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274-1283. doi: 10. 1038/ng. 2797.
26. Miller CL, Haas U, Diaz R, Leeper NJ, Kundu RK, Patlolla B, Assimes TL, Kaiser FJ, Perisic L, Hedin U, Maegdefessel L, Schunkert H, Erdmann J, Quertermous T, Sczakiel G. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet. 2014;10:e1004263. doi: 10. 1371/journal. pgen. 1004263.
27. Barenboim M, Zoltick BJ, Guo Y, Weinberger DR. MicroSNiPer: A web tool for prediction of SNP effects on putative microRNA targets. Hum Mutat. 2010;31:1223-1232. doi: 10. 1002/humu. 21349.
28. Sexton T, Bantignies F, Cavalli G. Genomic interactions: chromatin loops and gene meeting points in transcriptional regulation. Semin Cell Dev Biol. 2009;20:849-855. doi: 10. 1016/j. semcdb. 2009. 06. 004.
29. Sanyal A, Lajoie BR, Jain G, Dekker J. The long-range interaction landscape of gene promoters. Nature. 2012;489:109-113. doi: 10. 1038/ nature11279.
30. Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, Purcell SM, Sklar P, Scolnick EM, Xavier RJ, Altshuler D, Daly MJ; International Schizophrenia Consortium. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 2009;5:e1000534. doi: 10. 1371/journal. pgen. 1000534.
31. Pers TH, Karjalainen JM, Chan Y, et al; Genetic Investigation of ANthropometric Traits (GIANT) Consortium. Biological interpretation of genome-wide association studies using predicted gene functions. Nat Commun. 2015;6:5890. doi: 10. 1038/ncomms6890.
32. Eppig JT, Blake JA, Bult CJ, Kadin JA, Richardson JE; Mouse Genome Database Group. The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res. 2012;40(Database issue):D881-D886. doi: 10. 1093/nar/gkr974.
33. Osborne JD, Flatow J, Holko M, Lin SM, Kibbe WA, Zhu LJ, Danila MI, Feng G, Chisholm RL. Annotating the human genome with Disease Ontology. BMC Genomics. 2009;10(suppl 1):S6. doi: 10. 1186/1471-2164-10-S1-S6.
34. Kamburov A, Stelzl U, Lehrach H, Herwig R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res. 2013;41(Database issue):D793-D800. doi: 10. 1093/nar/gks1055.
35. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25-29 doi: 10. 1038/75556.
36. Gene Ontology C. Gene ontology consortium: Going forward. Nucleic acids research. 2015;43:D1049-D1056.
37. Ghazalpour A, Rau CD, Farber CR, et al. Hybrid mouse diversity panel: A panel of inbred mouse strains suitable for analysis of complex genetic traits. Mamm Genome. 2012;23:680-692. doi: 10. 1007/s00335-012-9411-5.
38. Cheong A, Bingham AJ, Li J, Kumar B, Sukumar P, Munsch C, Buckley NJ, Neylon CB, Porter KE, Beech DJ, Wood IC. Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol Cell. 2005;20:45-52. doi: 10. 1016/j. molcel. 2005. 08. 030.
39. Thorens B. Glucagon-like peptide-1 and control of insulin secretion. Diabete Metab. 1995;21:311-318.
40. Miyawaki K, Yamada Y, Ban N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. 2002;8:738-742. doi: 10. 1038/nm727.
41. Nasteska D, Harada N, Suzuki K, Yamane S, Hamasaki A, Joo E, Iwasaki K, Shibue K, Harada T, Inagaki N. Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions. Diabetes. 2014;63:2332-2343. doi: 10. 2337/db13-1563.
42. Nagase T, Kikuno R, Ishikawa K, Hirosawa M, Ohara O. Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 2000;7:143-150.
43. Warkman AS, Whitman SA, Miller MK, Garriock RJ, Schwach CM, Gregorio CC, Krieg PA. Developmental expression and cardiac transcriptional regulation of Myh7b, a third myosin heavy chain in the vertebrate heart. Cytoskeleton (Hoboken). 2012;69:324-335. doi: 10. 1002/cm. 21029.
44. Erdmann J, Stark K, Esslinger UB, et al; CARDIoGRAM. Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature. 2013;504:432-436. doi: 10. 1038/nature12722.
45. Miller CL, Anderson DR, Kundu RK, Raiesdana A, Nürnberg ST, Diaz R, Cheng K, Leeper NJ, Chen CH, Chang IS, Schadt EE, Hsiung CA, Assimes TL, Quertermous T. Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23. 2 coronary heart disease locus. PLoS Genet. 2013;9:e1003652. doi: 10. 1371/journal. pgen. 1003652.
46. Holdt LM, Teupser D. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol. 2012;32:196-206. doi: 10. 1161/ ATVBAHA. 111. 232678.
47. Albert FW, Kruglyak L. The role of regulatory variation in complex traits and disease. Nat Rev Genet. 2015;16:197-212. doi: 10. 1038/nrg3891.
48. Smemo S, Tena JJ, Kim KH, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507:371-375. doi: 10. 1038/nature13138.
49. Miller CL, Haas U, Diaz R, Leeper NJ, Kundu RK, Patlolla B, Assimes TL, Kaiser FJ, Perisic L, Hedin U, Maegdefessel L, Schunkert H, Erdmann J, Quertermous T, Sczakiel G. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet. 2014;10:e1004263. doi: 10. 1371/journal. pgen. 1004263.
50. Nica AC, Parts L, Glass D, et al; MuTHER Consortium. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 2011;7:e1002003. doi: 10. 1371/journal. pgen. 1002003.
51. Brown CD, Mangravite LM, Engelhardt BE. Integrative modeling of eQTLs and cis-regulatory elements suggests mechanisms underlying cell type specificity of eQTLs. PLoS Genet. 2013;9:e1003649. doi: 10. 1371/ journal. pgen. 1003649.
52. Fu J, Wolfs MG, Deelen P, et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet. 2012;8:e1002431. doi: 10. 1371/journal. pgen. 1002431.
53. Edwards SL, Beesley J, French JD, Dunning AM. Beyond GWASs: illuminating the dark road from association to function. Am J Hum Genet. 2013;93:779-797. doi: 10. 1016/j. Ajhg. 2013. 10. 012.
54. Barabasi AL, Albert R. Emergence of scaling in random networks. Science. 1999;286:509-512.
55. Jonas S, Izaurralde E. Towards a molecular understanding of microRNAmediated gene silencing. Nat Rev Genet. 2015;16:421-433. doi: 10. 1038/ nrg3965.
56. Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15:423-437. doi: 10. 1038/nrg3722.
57. Dostie J, Dekker J. Mapping networks of physical interactions between genomic elements using 5C technology. Nat Protoc. 2007;2:988-1002. doi: 10. 1038/nprot. 2007. 116.
58. Lee D, Gorkin DU, Baker M, Strober BJ, Asoni AL, McCallion AS, Beer MA. A method to predict the impact of regulatory variants from DNA sequence. Nat Genet. 2015;47:955-961. doi: 10. 1038/ng. 3331.